XML 19 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 71,425 $ 348,607
Restricted cash 0 300,000
Accounts receivable 0 349
Short-term investments 114,817 0
Prepaid expenses 2,441 1,504
Other current assets 181 486
Research and development tax credit receivable 848 5,766
Total current assets 189,712 656,712
Non-current assets:    
Property and equipment, net 204 906
Right-of-use assets 5,859 4,175
Goodwill 1,893 1,798
Research and development tax credit receivable 959 0
Other assets 4,322 577
Total assets 202,949 664,168
Current liabilities:    
Accounts payable 2,667 355
Accrued liabilities 8,783 10,664
Accrued compensation 5,429 5,641
Lease liabilities 2,809 1,690
Other current liabilities 717 662
Promissory note payable to related parties 0 19,770
Total current liabilities $ 20,405 $ 38,782
Notes Payable, Current, Related Party, Type [Extensible Enumeration] Related party Related party
Non-current liabilities    
Lease liabilities, net of current portion $ 3,290 $ 2,763
Other non-current liabilities 1,562 1,429
Promissory notes payable to related parties $ 100,000 $ 494,540
Notes Payable, Noncurrent, Related Party, Type [Extensible Enumeration] Related party Related party
Total liabilities $ 125,257 $ 537,514
Commitments and contingencies (Note 22)
Stockholders’ equity:    
Preferred stock, $0.01 par value, 20,000,000 shares authorized; none issued and outstanding at December 31, 2023 and 2022, respectively 0 0
Common stock, $0.01 par value: 1,000,000,000 shares authorized; 701,660,053 and 211,091,425 shares issued and outstanding at December 31, 2023 and 2022, respectively 7,017 2,110
Additional paid-in capital 1,066,381 504,767
Accumulated other comprehensive loss (2,448) (1,893)
Accumulated deficit (993,258) (378,330)
Total stockholders’ equity 77,692 126,654
Total liabilities and stockholders’ equity $ 202,949 $ 664,168